Uniphar announces deal for US based-RRD International Irish pharmaceuticals group Uniphar has today announced a deal to buy US-based RRD International. Business • 24 Nov 20
Uniphar announces deal for US based-RRD International Irish pharmaceuticals group Uniphar has today announced a deal to buy US-based RRD International. Business • 24 Nov 20
Uniphar buys US-based Diligent Health Solutions Irish pharmaceuticals group Uniphar has announced a deal to buy US-based Diligent Health Solutions for up to $27m. Business • 23 Sep 20
Uniphar buys US-based Diligent Health Solutions Irish pharmaceuticals group Uniphar has announced a deal to buy US-based Diligent Health Solutions for up to $27m. Business • 23 Sep 20
Competition watchdog to look at Uniphar-Hickey's deal The proposed acquisition by Uniphar of Hickey's Pharmacy Group has been notified to the Competition and Consumer Protection Commission. Business • 14 Sep 20
Competition watchdog to look at Uniphar-Hickey's deal The proposed acquisition by Uniphar of Hickey's Pharmacy Group has been notified to the Competition and Consumer Protection Commission. Business • 14 Sep 20
Uniphar to buy Hickey's pharma chain as H1 profits rise Irish pharmaceuticals group Uniphar has announced a deal to buy Hickey's, a chain of pharmacies in Ireland, which it said will further strengthen its market share. Business • 02 Sep 20
Uniphar to buy Hickey's pharma chain as H1 profits rise Irish pharmaceuticals group Uniphar has announced a deal to buy Hickey's, a chain of pharmacies in Ireland, which it said will further strengthen its market share. Business • 02 Sep 20
Uniphar performing in line with expectations Irish pharmaceuticals group Uniphar has said business performed in line with expectations for the six months to June 2020 at both a gross profit and EBITDA level. Business • 28 Jul 20
Uniphar performing in line with expectations Irish pharmaceuticals group Uniphar has said business performed in line with expectations for the six months to June 2020 at both a gross profit and EBITDA level. Business • 28 Jul 20
Uniphar's 2019 growth in line with expectations Uniphar says it achieved gross organic profit growth of 7% last year, in line with its expectations. Business • 04 Feb 20
Uniphar's 2019 growth in line with expectations Uniphar says it achieved gross organic profit growth of 7% last year, in line with its expectations. Business • 04 Feb 20
Uniphar buys Irish and Nordic firms for €40m Healthcare services business Uniphar has announced two acquisitions today - Nordic-based medtech service provider, EPS Group and Irish-based medtech service provider M3 Medical. Business • 19 Nov 19
Uniphar buys Irish and Nordic firms for €40m Healthcare services business Uniphar has announced two acquisitions today - Nordic-based medtech service provider, EPS Group and Irish-based medtech service provider M3 Medical. Business • 19 Nov 19
Uniphar's half yearly profits and revenues soar Irish pharmaceuticals group Uniphar has reported surging profits and revenues for the six months to the end of June after its IPO in July. Business • 17 Sep 19
Uniphar's half yearly profits and revenues soar Irish pharmaceuticals group Uniphar has reported surging profits and revenues for the six months to the end of June after its IPO in July. Business • 17 Sep 19
Uniphar shares jump on Euronext Dublin debut Shares in diversified healthcare services Uniphar jumped as much as 6% today on the company's first day of trade on Euronext Dublin's Growth index. Business • 17 Jul 19
Uniphar shares jump on Euronext Dublin debut Shares in diversified healthcare services Uniphar jumped as much as 6% today on the company's first day of trade on Euronext Dublin's Growth index. Business • 17 Jul 19
Uniphar raises €150m from Dublin and London listing Irish pharmaceuticals group Uniphar has raised its target of €150m from the issue of new shares as it lists on the Dublin and London stock exchanges. Business • 12 Jul 19
Uniphar raises €150m from Dublin and London listing Irish pharmaceuticals group Uniphar has raised its target of €150m from the issue of new shares as it lists on the Dublin and London stock exchanges. Business • 12 Jul 19
Uniphar set to float on Euronext Dublin & London's AIM Irish headquartered healthcare service business Uniphar has announced its intention to float on Euronext Dublin and the Alternative Investment Market or AIM in London. Business • 17 Jun 19
Uniphar set to float on Euronext Dublin & London's AIM Irish headquartered healthcare service business Uniphar has announced its intention to float on Euronext Dublin and the Alternative Investment Market or AIM in London. Business • 17 Jun 19
Pharma group Uniphar eyes stock market listing - source Irish pharmaceuticals group Uniphar has hired stockbroker Davy and RBC Capital Markets to sound out investors for a possible initial public offering (IPO) in 2019, a source familiar with the matter said today. Business • 25 Apr 19
Pharma group Uniphar eyes stock market listing - source Irish pharmaceuticals group Uniphar has hired stockbroker Davy and RBC Capital Markets to sound out investors for a possible initial public offering (IPO) in 2019, a source familiar with the matter said today. Business • 25 Apr 19
